Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies

For several decades, serological biomarkers of neuromuscular diseases as dystrophies, myopathies and myositis have been limited to routine clinical biochemistry panels. Gauging the pathological progression is a prerequisite for proper treatment and therefore identifying accessible, easy to monitor b...

Descripción completa

Detalles Bibliográficos
Autores principales: Arvanitidis, A., Henriksen, K., Karsdal, M.A., Nedergaard, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123625/
https://www.ncbi.nlm.nih.gov/pubmed/27854226
http://dx.doi.org/10.3233/JND-160150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123625/
https://www.ncbi.nlm.nih.gov/pubmed/27854226
http://dx.doi.org/10.3233/JND-160150

Ejemplares similares